1

2

3
Cheng Hengmiao, Cripps Stephan James, Dress Klaus Ruprecht, Huang Buwen, Nair Sajiv Krishnan, Wang Yong: Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase. Pfizer, Cheng Hengmiao, Cripps Stephan James, Dress Klaus Ruprecht, Huang Buwen, Nair Sajiv Krishnan, Wang Yong, FULLER Grover F Jr, October 12, 2006: WO/2006/106423 (23 worldwide citation)

The present invention relates to compounds with Formula (I) or a pharmaceutically acceptable salt thereof: Formula (I); wherein R1 is an optionally fused pyridine ring and R2 and R3 together form a heterocyclic ring. The invention also relates to pharmaceutical compositions comprising the compounds ...


4
Cheng Hengmiao, Cripps Stephan James, Lafontaine Jennifer Anne, Le Phuong Thi Quy, Matthews Jean Joo, Nair Sajiv Krishnan: Sulfonyl derivatives. Pfizer Products, Cheng Hengmiao, Cripps Stephan James, Lafontaine Jennifer Anne, Le Phuong Thi Quy, Matthews Jean Joo, Nair Sajiv Krishnan, FULLER Grover F Jr, May 24, 2007: WO/2007/057768 (3 worldwide citation)

The present invention relates to compounds, pharmaceutical compositions comprising these compounds and methods for treating a condition that is mediated by the modulation of the 11-&bgr;-hsd-1 enzyme.


5
Kania Robert Steven, Bender Steven Lee, Borchardt Allen J, Braganza John F, Cripps Stephan James, Hua Ye, Johnson Michael David, Johnson Theodore Otto Jr, Luu Hiep The, Palmer Cynthia Louise, Reich Siegfried Heinz, Tempczyk Russell Anna Maria, Teng Min, Thomas Christine, Varney Michael David, Wallace Michael Brennan, Collins Michael Raymond: Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use. Agouron Pharmaceuticals, PINO Mark J, January 11, 2001: WO/2001/002369 (3 worldwide citation)

Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The inv ...


6
Bender Steven Lee, Bhumralkar Dilip, Collins Michael Raymond, Cripps Stephan James, Deal Judith Gail, Nambu Mitchell David, Palmer Cynthia Louise, Peng Zhengwei, Varney Michael David, Jia Lei: Amide compounds for inhibiting protein kinases. Agouron Pharmaceuticals, GADIANO Christina, July 26, 2001: WO/2001/053274 (2 worldwide citation)

Amide compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/or inhibit unwanted cell proliferation. The invent ...


7
Collins Michael Raymond, Tempczyk Russell Anna Maria, Hua Ye, Johnson Michael David, Bender Steven Lee, Kania Robert Steven, Borchardt Allen J, Braganza John F, Cripps Stephan James, Johnson Theodore Otto Jr, Luu Hiep The, Palmer Cynthia Louise, Reich Siegfried Heinz, Teng Min, Thomas Christine, Varney Michael David, Wallace Michael Brennan: Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use. Agouron Pharma, January 11, 2006: EP1614683-A1 (1 worldwide citation)

Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The inv ...


8

9

10